Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 439

1.

Metabolic effects of the natural sweeteners xylitol and erythritol: A comprehensive review.

Wölnerhanssen BK, Meyer-Gerspach AC, Beglinger C, Islam MS.

Crit Rev Food Sci Nutr. 2019 Jun 16:1-13. doi: 10.1080/10408398.2019.1623757. [Epub ahead of print]

PMID:
31204494
2.

Quantification of Liver, Subcutaneous, and Visceral Adipose Tissues by MRI Before and After Bariatric Surgery.

Meyer-Gerspach AC, Peterli R, Moor M, Madörin P, Schötzau A, Nabers D, Borgwardt S, Beglinger C, Bieri O, Wölnerhanssen BK.

Obes Surg. 2019 Sep;29(9):2795-2805. doi: 10.1007/s11695-019-03897-2.

3.

Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn's Disease Patients.

Kaymak T, Moriconi F, Niess JH, Beglinger C, Hruz P.

Inflamm Intest Dis. 2018 Mar;2(3):171-179. doi: 10.1159/000486676. Epub 2018 Feb 21.

4.

Endogenous GLP-1 alters postprandial functional connectivity between homeostatic and reward-related brain regions involved in regulation of appetite in healthy lean males: A pilotstudy.

Meyer-Gerspach AC, Ly HG, Borgwardt S, Dupont P, Beglinger C, Van Oudenhove L, Wölnerhanssen BK.

Diabetes Obes Metab. 2018 Oct;20(10):2330-2338. doi: 10.1111/dom.13369. Epub 2018 Jun 10.

PMID:
29790260
5.

Acute Effects of Glucose and Fructose Administration on the Neural Correlates of Cognitive Functioning in Healthy Subjects: A Pilot Study.

Zanchi D, Meyer-Gerspach AC, Schmidt A, Suenderhauf C, Depoorter A, Drewe J, Beglinger C, Wölnerhanssen BK, Borgwardt S.

Front Psychiatry. 2018 Mar 12;9:71. doi: 10.3389/fpsyt.2018.00071. eCollection 2018.

6.

Insulin resistance causes inflammation in adipose tissue.

Shimobayashi M, Albert V, Woelnerhanssen B, Frei IC, Weissenberger D, Meyer-Gerspach AC, Clement N, Moes S, Colombi M, Meier JA, Swierczynska MM, Jenö P, Beglinger C, Peterli R, Hall MN.

J Clin Invest. 2018 Apr 2;128(4):1538-1550. doi: 10.1172/JCI96139. Epub 2018 Mar 12.

7.

The impact of preoperative investigations on the management of bariatric patients; results of a cohort of more than 1200 cases.

Schneider R, Lazaridis I, Kraljević M, Beglinger C, Wölnerhanssen B, Peterli R.

Surg Obes Relat Dis. 2018 May;14(5):693-699. doi: 10.1016/j.soard.2018.01.009. Epub 2018 Jan 12.

PMID:
29519608
8.

Pediatric Dilated Cardiomyopathy-Associated LRRC10 (Leucine-Rich Repeat-Containing 10) Variant Reveals LRRC10 as an Auxiliary Subunit of Cardiac L-Type Ca2+ Channels.

Woon MT, Long PA, Reilly L, Evans JM, Keefe AM, Lea MR, Beglinger CJ, Balijepalli RC, Lee Y, Olson TM, Kamp TJ.

J Am Heart Assoc. 2018 Feb 3;7(3). pii: e006428. doi: 10.1161/JAHA.117.006428.

9.

Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.

Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D, Borbély Y, Schultes B, Beglinger C, Drewe J, Schiesser M, Nett P, Bueter M.

JAMA. 2018 Jan 16;319(3):255-265. doi: 10.1001/jama.2017.20897.

10.

Green tea effects on cognition, mood and human brain function: A systematic review.

Mancini E, Beglinger C, Drewe J, Zanchi D, Lang UE, Borgwardt S.

Phytomedicine. 2017 Oct 15;34:26-37. doi: 10.1016/j.phymed.2017.07.008. Epub 2017 Jul 27. Review.

PMID:
28899506
11.

Deregulation of transcription factors controlling intestinal epithelial cell differentiation; a predisposing factor for reduced enteroendocrine cell number in morbidly obese individuals.

Wölnerhanssen BK, Moran AW, Burdyga G, Meyer-Gerspach AC, Peterli R, Manz M, Thumshirn M, Daly K, Beglinger C, Shirazi-Beechey SP.

Sci Rep. 2017 Aug 15;7(1):8174. doi: 10.1038/s41598-017-08487-9.

12.

The impact of gut hormones on the neural circuit of appetite and satiety: A systematic review.

Zanchi D, Depoorter A, Egloff L, Haller S, Mählmann L, Lang UE, Drewe J, Beglinger C, Schmidt A, Borgwardt S.

Neurosci Biobehav Rev. 2017 Sep;80:457-475. doi: 10.1016/j.neubiorev.2017.06.013. Epub 2017 Jun 29. Review.

13.

Extracellular vesicles in gastrointestinal cancer in conjunction with microbiota: On the border of Kingdoms.

Barteneva NS, Baiken Y, Fasler-Kan E, Alibek K, Wang S, Maltsev N, Ponomarev ED, Sautbayeva Z, Kauanova S, Moore A, Beglinger C, Vorobjev IA.

Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):372-393. doi: 10.1016/j.bbcan.2017.06.005. Epub 2017 Jun 29. Review.

14.

Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS).

Peterli R, Wölnerhanssen BK, Vetter D, Nett P, Gass M, Borbély Y, Peters T, Schiesser M, Schultes B, Beglinger C, Drewe J, Bueter M.

Ann Surg. 2017 Mar;265(3):466-473. doi: 10.1097/SLA.0000000000001929.

15.

Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Geary N.

Physiol Rev. 2017 Jan;97(1):411-463. doi: 10.1152/physrev.00031.2014. Review. Erratum in: Physiol Rev. 2017 Jul 1;97(3):1229.

16.

Characterizing the dynamic interaction among gastric emptying, glucose absorption, and glycemic control in nondiabetic obese adults.

Wilbaux M, Wölnerhanssen BK, Meyer-Gerspach AC, Beglinger C, Pfister M.

Am J Physiol Regul Integr Comp Physiol. 2017 Mar 1;312(3):R314-R323. doi: 10.1152/ajpregu.00369.2016. Epub 2016 Dec 14.

17.

Effect of L-Tryptophan and L-Leucine on Gut Hormone Secretion, Appetite Feelings and Gastric Emptying Rates in Lean and Non-Diabetic Obese Participants: A Randomized, Double-Blind, Parallel-Group Trial.

Meyer-Gerspach AC, Häfliger S, Meili J, Doody A, Rehfeld JF, Drewe J, Beglinger C, Wölnerhanssen B.

PLoS One. 2016 Nov 22;11(11):e0166758. doi: 10.1371/journal.pone.0166758. eCollection 2016.

18.

Incretin effects, gastric emptying and insulin responses to low oral glucose loads in patients after gastric bypass and lean and obese controls.

Wölnerhanssen BK, Meyer-Gerspach AC, Peters T, Beglinger C, Peterli R.

Surg Obes Relat Dis. 2016 Aug;12(7):1320-1327. doi: 10.1016/j.soard.2015.11.022. Epub 2015 Nov 27.

19.

Differential effects of L-tryptophan and L-leucine administration on brain resting state functional networks and plasma hormone levels.

Zanchi D, Meyer-Gerspach AC, Suenderhauf C, Janach K, le Roux CW, Haller S, Drewe J, Beglinger C, Wölnerhanssen BK, Borgwardt S.

Sci Rep. 2016 Oct 20;6:35727. doi: 10.1038/srep35727.

20.

Reply to letter to the editor: the tolerance of erythritol and xylitol based on effective dose methodologies.

Wölnerhanssen BK, Meyer Gerspach AC, Beglinger C.

Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E762. doi: 10.1152/ajpendo.00335.2016. No abstract available.

21.

Gut Taste Stimulants Alter Brain Activity in Areas Related to Working Memory: a Pilot Study.

Meyer-Gerspach AC, Suenderhauf C, Bereiter L, Zanchi D, Beglinger C, Borgwardt S, Wölnerhanssen BK.

Neurosignals. 2016;24(1):59-70. doi: 10.1159/000442612. Epub 2016 Jul 27.

22.

Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer.

Ciarloni L, Ehrensberger SH, Imaizumi N, Monnier-Benoit S, Nichita C, Myung SJ, Kim JS, Song SY, Kim TI, van der Weg B, Meier R, Borovicka J, Beglinger C, Vallet C, Maerten P, Rüegg C, Dorta G.

Clin Cancer Res. 2016 Sep 15;22(18):4604-11. doi: 10.1158/1078-0432.CCR-15-2057. Epub 2016 Apr 28.

23.

Gut hormone secretion, gastric emptying, and glycemic responses to erythritol and xylitol in lean and obese subjects.

Wölnerhanssen BK, Cajacob L, Keller N, Doody A, Rehfeld JF, Drewe J, Peterli R, Beglinger C, Meyer-Gerspach AC.

Am J Physiol Endocrinol Metab. 2016 Jun 1;310(11):E1053-61. doi: 10.1152/ajpendo.00037.2016. Epub 2016 Apr 26.

24.

Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.

Meyer-Gerspach AC, Cajacob L, Riva D, Herzog R, Drewe J, Beglinger C, Wölnerhanssen BK.

PLoS One. 2016 Mar 4;11(3):e0150803. doi: 10.1371/journal.pone.0150803. eCollection 2016.

25.

Functional roles of low calorie sweeteners on gut function.

Meyer-Gerspach AC, Wölnerhanssen B, Beglinger C.

Physiol Behav. 2016 Oct 1;164(Pt B):479-481. doi: 10.1016/j.physbeh.2016.01.045. Epub 2016 Feb 6. Review.

PMID:
26861179
26.

Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists.

Vavricka SR, Sulz MC, Degen L, Rechner R, Manz M, Biedermann L, Beglinger C, Peter S, Safroneeva E, Rogler G, Schoepfer AM.

Endoscopy. 2016 Mar;48(3):256-62. doi: 10.1055/s-0035-1569674. Epub 2016 Jan 25.

PMID:
26808396
27.

English language version of the S3-consensus guidelines on chronic pancreatitis: Definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis.

Hoffmeister A, Mayerle J, Beglinger C, Büchler MW, Bufler P, Dathe K, Fölsch UR, Friess H, Izbicki J, Kahl S, Klar E, Keller J, Knoefel WT, Layer P, Loehr M, Meier R, Riemann JF, Rünzi M, Schmid RM, Schreyer A, Tribl B, Werner J, Witt H, Mössner J, Lerch MM; members of the guideline committee.

Z Gastroenterol. 2015 Dec;53(12):1447-95. doi: 10.1055/s-0041-107379. Epub 2015 Dec 14.

28.

Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.

Bernsmeier C, Weisskopf DM, Pflueger MO, Mosimann J, Campana B, Terracciano L, Beglinger C, Heim MH, Cajochen C.

PLoS One. 2015 Nov 17;10(11):e0143293. doi: 10.1371/journal.pone.0143293. eCollection 2015.

29.

Gastric emptying and disease activity in inflammatory bowel disease.

Keller J, Binnewies U, Rösch M, Juul Holst J, Beglinger C, Andresen V, Layer P.

Eur J Clin Invest. 2015 Dec;45(12):1234-42. doi: 10.1111/eci.12542. Epub 2015 Nov 2.

PMID:
26426315
30.

Nutritional aspects of depression.

Lang UE, Beglinger C, Schweinfurth N, Walter M, Borgwardt S.

Cell Physiol Biochem. 2015;37(3):1029-43. doi: 10.1159/000430229. Epub 2015 Sep 25. Review.

31.

Lean and obese dietary phenotypes: differences in energy and substrate metabolism and appetite.

Clamp L, Hehir AP, Lambert EV, Beglinger C, Goedecke JH.

Br J Nutr. 2015 Nov 28;114(10):1724-33. doi: 10.1017/S0007114515003402. Epub 2015 Sep 18.

PMID:
26382929
32.

Intestinal GLP-1 and satiation: from man to rodents and back.

Steinert RE, Beglinger C, Langhans W.

Int J Obes (Lond). 2016 Feb;40(2):198-205. doi: 10.1038/ijo.2015.172. Epub 2015 Aug 28. Review.

PMID:
26315842
33.

Serum Levels of Human MIC-1/GDF15 Vary in a Diurnal Pattern, Do Not Display a Profile Suggestive of a Satiety Factor and Are Related to BMI.

Tsai VW, Macia L, Feinle-Bisset C, Manandhar R, Astrup A, Raben A, Lorenzen JK, Schmidt PT, Wiklund F, Pedersen NL, Campbell L, Kriketos A, Xu A, Pengcheng Z, Jia W, Curmi PM, Angstmann CN, Lee-Ng KK, Zhang HP, Marquis CP, Husaini Y, Beglinger C, Lin S, Herzog H, Brown DA, Sainsbury A, Breit SN.

PLoS One. 2015 Jul 24;10(7):e0133362. doi: 10.1371/journal.pone.0133362. eCollection 2015.

34.

Dissociable Behavioral, Physiological and Neural Effects of Acute Glucose and Fructose Ingestion: A Pilot Study.

Wölnerhanssen BK, Meyer-Gerspach AC, Schmidt A, Zimak N, Peterli R, Beglinger C, Borgwardt S.

PLoS One. 2015 Jun 24;10(6):e0130280. doi: 10.1371/journal.pone.0130280. eCollection 2015.

35.

Reply: To PMID 25344905.

Burri E, Beglinger C, Lehmann FS.

Dig Dis Sci. 2015 Apr;60(4):1109-10. No abstract available.

PMID:
26086059
36.

The role and utility of faecal markers in inflammatory bowel disease.

Lehmann FS, Burri E, Beglinger C.

Therap Adv Gastroenterol. 2015 Jan;8(1):23-36. doi: 10.1177/1756283X14553384. Review.

37.

Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitis.

Burri E, Beglinger C, von Felten S, Lehmann FS.

Dig Dis Sci. 2015 Feb;60(2):485-91. doi: 10.1007/s10620-014-3383-0. Epub 2014 Oct 26.

PMID:
25344905
38.

Exercise-induced chest pain: an atypical manifestation of eosinophilic esophagitis.

Kahn J, Bussmann C, Beglinger C, Straumann A, Hruz P.

Am J Med. 2015 Feb;128(2):196-9. doi: 10.1016/j.amjmed.2014.08.007. Epub 2014 Sep 23.

PMID:
25261012
39.

IBD: Faecal calprotectin testing--the need for better standardization.

Burri E, Beglinger C.

Nat Rev Gastroenterol Hepatol. 2014 Oct;11(10):583-4. doi: 10.1038/nrgastro.2014.154. Epub 2014 Sep 9.

PMID:
25201042
40.

Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendations.

Sauter B, Beglinger C, Girardin M, Macpherson A, Michetti P, Schoepfer A, Seibold F, Vavricka SR, Rogler G.

Digestion. 2014;89(4):299-309. doi: 10.1159/000360283. Epub 2014 Jul 25.

41.

Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.

Steinert RE, Schirra J, Meyer-Gerspach AC, Kienle P, Fischer H, Schulte F, Goeke B, Beglinger C.

Am J Clin Nutr. 2014 Aug;100(2):514-23. doi: 10.3945/ajcn.114.083246. Epub 2014 Jun 25.

PMID:
24965303
42.

Effect of a test meal on meal responses of satiation hormones and their association to insulin resistance in obese adolescents.

Beglinger S, Meyer-Gerspach AC, Graf S, Zumsteg U, Drewe J, Beglinger C, Gutzwiller JP.

Obesity (Silver Spring). 2014 Sep;22(9):2047-52. doi: 10.1002/oby.20805. Epub 2014 Jun 13.

43.

The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.

Protic M, Seibold F, Schoepfer A, Radojicic Z, Juillerat P, Bojic D, Mwinyi J, Mottet C, Jojic N, Beglinger C, Vavricka S, Rogler G, Frei P.

J Crohns Colitis. 2014 Nov;8(11):1427-37. doi: 10.1016/j.crohns.2014.05.004. Epub 2014 Jun 5.

PMID:
24908178
44.

Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.

Mecklenburg I, Reznik D, Fasler-Kan E, Drewe J, Beglinger C, Hruz P; Swiss IBD Cohort Study Group.

J Crohns Colitis. 2014 Nov;8(11):1392-7. doi: 10.1016/j.crohns.2014.04.008. Epub 2014 May 11.

PMID:
24825446
45.

Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma.

Lehmann FS, Trapani F, Fueglistaler I, Terracciano LM, von Flüe M, Cathomas G, Zettl A, Benkert P, Oertli D, Beglinger C.

World J Gastroenterol. 2014 May 7;20(17):4994-9. doi: 10.3748/wjg.v20.i17.4994.

46.

Gut sweet taste receptors and their role in metabolism.

Meyer-Gerspach AC, Wölnerhanssen B, Beglinger C.

Front Horm Res. 2014;42:123-33. doi: 10.1159/000358321. Epub 2014 Apr 7. Review.

PMID:
24732930
47.

Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness.

Burri E, Manz M, Schroeder P, Froehlich F, Rossi L, Beglinger C, Lehmann FS.

BMC Gastroenterol. 2014 Mar 29;14:57. doi: 10.1186/1471-230X-14-57.

48.

Green tea extract enhances parieto-frontal connectivity during working memory processing.

Schmidt A, Hammann F, Wölnerhanssen B, Meyer-Gerspach AC, Drewe J, Beglinger C, Borgwardt S.

Psychopharmacology (Berl). 2014 Oct;231(19):3879-88. doi: 10.1007/s00213-014-3526-1. Epub 2014 Mar 19.

49.

Gastric and intestinal satiation in obese and normal weight healthy people.

Meyer-Gerspach AC, Wölnerhanssen B, Beglinger B, Nessenius F, Napitupulu M, Schulte FH, Steinert RE, Beglinger C.

Physiol Behav. 2014 Apr 22;129:265-71. doi: 10.1016/j.physbeh.2014.02.043. Epub 2014 Feb 28.

PMID:
24582673
50.

Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.

Bernsmeier C, Meyer-Gerspach AC, Blaser LS, Jeker L, Steinert RE, Heim MH, Beglinger C.

PLoS One. 2014 Jan 29;9(1):e87488. doi: 10.1371/journal.pone.0087488. eCollection 2014.

Supplemental Content

Loading ...
Support Center